Serum concentration of the soluble interleukin-2 receptor in vitiligo patients

Journal of Dermatological Science

Volumn 19, Issue 3, 1999, Pages 182-188

  Yeo, Un Cheol ^a   Yang, Yoon Sun ^a   Park, Ki Beom ^a   Sung, Hwan Tae ^a   Jung, Seung Yong ^a   Lee, Eil Soo ^a   Shin, Myung Hee ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

ELISA; Soluble interleukin 2 receptor; Vitiligo

Indexed keywords

INTERLEUKIN 2 RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD LEVEL; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; VITILIGO;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; CHILD; CHILD, PRESCHOOL; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; SOLUBILITY; TIME FACTORS; VITILIGO;

EID: 0344267746     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(98)00070-X     Document Type: Article

References (29)

1. Goldsmith M.A., Greene W.C. Interleukin-2 and the interleukin-2 receptor. Thomson A. The Cytokine Handbook, 2nd ed. 1994;55-80 Academic Press, London.
2. Gaulton G.N., Williamson P. Interleukin-2 and the interleukin-2 receptor complex. Chem. Immunol. 59:1994;91-114.
3. Rubin L.A., Nelson D.L. The soluble interleukin-2 receptor: biology, function, and clinical application. Ann. Intern. Med. 113:1990;619-627.
4. Kemmett D., Symons J.A., Colver G.B., Duff G.W. Serum-soluble interleukin 2 receptor in psoriasis:failure to reflect clinical improvement. Acta. Derm.-Venereol. 70:1990;264-267.
5. Vonderheid E.C., Kang C.A., Kadin M., Bigler R.D., Griffin T.D., Rogers T.J. Extracorporeal photopheresis in psoriasis vulgaris:clinical and immunologic observations. J. Am. Acad. Dermatol. 23:1990;703-712.
6. Takematsu H., Tagami H. Interleukin 2, soluble interleukin 2 receptor, and interferon-in the suction blister fluid from psoriatic skin. Arch. Dermatol. Res. 282:1990;149-152.
7. Takashima A., Morita A. Genomic, phenotypic, and functional analysis of T cells in patients with psoriasis undergoing systemic cyclosporin A treatment. J. Invest. Dermatol. 96:1991;376-382.
8. Duncan J.I., Horrocks C., Ormerod A.D., Powels A.V., Whiting P.H., Fry L., Thomson A.W. Soluble Il-2 receptor and CD 25 cells in psoriasis:effects of cyclosporin A and PUVA therapy. Clin. Exp. Immunol. 85:1991;293-296.
9. Betti R., Rosti A., Lodi A., Bencini P.L., Paparelli S., Gazzola G.B., Cori P., Moroni G.A., Crosti C. Effects of UVB plus tar therapy on serum levels of interleukin-2 receptors in patients with psoriasis. Clin. Exp. Dermatol. 16:1991;364-366.
10. Elias A.N., Mathew M.G., Rohan M.K. Effect of propylthiouracil and methimazole on serum levels of interleukin-2 receptors in patients with psoriasis. Int. J. Dermatol. 32:1993;537-540.
11. Soyland E., Lea T., Sandstad B., Drevon A. Dietary supplementation with very long-chain fatty acids in man decrease expression of the interleukin-2 receptor(CD25) on mitogen-stimulated lymphocytes from patients with inflammatory skin disease. Eur. J. Clin. Invest. 24:1994;236-242.
12. De Rie M.A., Zonnevald I.M., Witkammp L., Witkamp L., Van Lier R.A.W., Out T.A., Bos J.D. Soluble interleukin-2 receptor(sIL-2R) is a marker of disease activity in psoriasis:a comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1. Acta. Derm.-Venereol. 76:1996;357-360.
13. Kapp A., Piskorski A., Schopt E. Elevated levels of interleukin 2 receptor in sera of patients with atopic dermatitis and psoriasis. Br. J. Dermatol. 119:1988;707-710.
14. Kapp A., Neuer P., Krutmann J., Luger T.A., Shopf E. Production of interleukin-2 by mononuclear cells in vitro in patients with atopic dermatitis and psoriasis. Acta. Derm.-Venereol. 71:1991;403-406.
15. Kagi M.K., Joller-Jemelka H., Wuithrich B. Correlation of eosinophils, cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis. Dermatology. 185:1992;88-92.
16. Wasik M.A., Vonderheid E.C., Bigler R.D., Marti R., Lessin S.R., Polansky M., Kadin M.E. Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Arch. Dermatol. 132:1996;42-47.
17. Bernengo M.G., Fierro M.T., Novelli M., Lisa F., Appino A. Soluble interleukin-2 receptor in Sezary syndrome:its origin and clinical application. Br. J. Dermatol. 128:1993;124-129.
18. Pollison R.P., Gilkeson G.S., Pyun E.H., Pisetsky D.S., Smith E.A., Simon L.S. A multicenter trial of recombinant human interferon gamma in patients with systemic sclerosis:effects on cutaneous fibrosis and interleukin 2 receptor levels. J. Rheumatol. 23:1996;654-658.
19. Kiener H., Graninger W., Machold K., Aringer M., Granninger W.B. Increased levels of circulating intercellular adhesion molecule-1 in patients with systemic sclerosis. Clin. Exp. Rheumatol. 12:1994;483-487.
20. Honda Y., Okubo Y., Koga M. Relationship between levels of soluble interleukin-2 receptors and the types and activity of vitiligo. J. Dermatol. 24:1997;561-563.
21. Abdel-Naser MB, Kruger-Krasagakes S, Krasagakis K, Gollnick H, Orfanos CE. Further evidence for involvement of both cell mediated and humoral immunity in generalized vitiligo. Pigment Cell Res 1994;7:1-8.
22. Wolkentein P., Revuz J., Guillaume J.C., Avril M.F., Chosidow O. Autoimmune disorders and interleukin-2 therapy:a step toward 'unanswered questions'. Arch. Dermatol. 131:1995;615.
23. Voss SD, Robb RJ. Receptors for interleukin-2 (IL-2). In: Nicola NA, editors. Guidebook to Cytokines and Their Receptors. Oxford: Sambrook and Tooze, 1994:31-37.
24. Rubin L.A., Kurman C.C., Fritz M.E., Biddison W.E., Boutin B., Yarchoan R., Nelson D.L. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J. Immunol. 135:1985;3172-3177.
25. Fernandes-Bortan R. Soluble cytokine receptors:their role in immunoregulation. FASEB J. 5:1991;2567-2574.
26. Ahn S.K., Choi E.H., Lee S.H. Immunohistochemical studies from vitiligo. Yonsei Med. J. 35:1994;404-410.
27. Gross A., Pais F.J., Mosca W. Mononuclear cell subpopulations and infiltrating lymphocytes in erythema dyschronicum perstans and vitiligo. Histol. Histopathol. 2:1987;277-287.
28. Abdel-Naser M.B., Gollnick H., Orfanos C.E. Evidence of primary involvement of keratinocytes in vitiligo. Arch. Dermatol. Res. 283:1991;47-48.
29. Lerner A.B. On the etiology of vitiligo and gray hair. Am. J. Med. 51:1975;147-156.